The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

TGTX FINANCIAL STATEMENTS

TG Therapeutics Inc — balance sheet, income statement and cash flow trends

TGTXTG Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M202020212022202420252026

Profit Funnel

Q2 2026 · TTM
Revenue799.5 M $Gross Profit658.5 M $ · 82%Operating Income136.3 M $ · 17%Pre-tax Income101.6 M $ · 13%Net Income to Owners441.5 M $ · 55%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue799.5 M $+76.1%
Gross Profit658.5 M $+66.8%
Operating Income136.3 M $+58.8%
EBITDA134.2 M $+37.3%
Net Income to Owners441.5 M $+630.2%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B1.5 B202020212022202420252026

Capital Structure

Q2 2026
Total Assets1.6 B
  • Equity604.1 M $37%
  • Current Liabilities268.5 M $16%
  • Long-term Liabilities767.1 M $47%

Key Figures

YoY change
Total Assets1.6 B $+133.4%
Total Liabilities1 B $+143.0%
Total Equity604.1 M $+118.5%
Cash & ST Investments552.2 M $+119.3%
Total Debt9.1 M $-96.4%
Net Debt-473.5 M $-480.1%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M0202020212022202420252026

Cash Flow Bridge

Q2 2026 · TTM
0100 M200 M300 M17.9 M $Operating21.9 M $Investing313.7 M $Financing353.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow17.9 M $—
Capital Expenditures491 K $+338.4%
Free Cash Flow17.4 M $—
Dividends Paid0 $—

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on TGTX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.